Company intelligence / Profile preview

Renata Pharmaceuticals

Dhaka, Dhaka, Bangladesh

Ownership: Private
Employees: ~8000
Development stage: Other

Overview

Renata Limited is one of the leading pharmaceutical and animal health product companies in Bangladesh. Originally founded as a subsidiary of Pfizer, it became a locally owned entity in 1993. The company is known for its high-quality generic drugs, extensive animal health portfolio, and international manufacturing certifications including UK MHRA and EU GMP approvals.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small moleculeVaccinePeptidesProtein
Industry: Biotech

Partnerships

UNICEFWorld Health OrganizationGAVISerum Institute of India

Beyond the preview

Go deeper on Renata Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renata Pharmaceuticals.

Explore the full profile